Coronavirus: Second COVID-19 vaccine to begin advanced clinical trials in the UK
The Novavax candidate is the second vaccine to enter Phase 3 clinical trials in the UK - the first was the potential vaccine being developed by Oxford University and AstraZeneca.
Gregory M Glenn, president of research and development at Novavax, said the team was"optimistic" that the trial would"provide a near-term view" of the vaccine's efficacy. He added:"The data from this trial is expected to support regulatory submissions for licensure in the UK, EU and other countries. "We are grateful for the support of the UK government, including from its Department of Health and Social Care and National Institute for Health Research, to advance this important research."Novavax said that pre-clinical trials showed the potential vaccine was"generally well-tolerated" and produced"robust antibody responses" greater than those seen in recovering patients.
Thomas Moore, Sky's science correspondent, said the Novavax trial could start as soon as Friday and that the vaccine candidate shows"huge promise".
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
J&J enters Phase III of clinical trial for its one-shot COVID vaccineOn Wednesday. Johnson & Johnson entered Phase III of clinical trials for its experimental coronavirus vaccine, which does not need to be frozen and may require just one dose instead of two.
Read more »
UK sees highest Covid cases since mass tests beganLatest figures show 6,634 new coronavirus cases across the UK, taking the total to 416,363.
Read more »
UK Covid-19 vaccine trial set to infect healthy volunteers with virusResearchers hope to begin world’s first human challenge trials at east London quarantine facility in January
Read more »
1 in 5 say they're 'unlikely' to get Covid vaccine amid misinformation fearsA FIFTH of Brits say they are unlikely to get a coronavirus jab – even if one is approved, a study has found. The new research highlights “concerning” levels of misinformation aro…
Read more »
FDA standards for coronavirus vaccine will delay it past election dayPresident Donald Trump claimed shot would be ready by 3 November
Read more »